Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Hansen Medical Inc (NASDAQ: HNSN) acted responsibly on behalf of investors’ profitability in the planned $80 million sale to Auris Surgical Robotics Inc.

On April 20, 2016, Hansen Medical Inc (NASDAQ: HNSN) and Auris Surgical Robotics Inc announced that they had entered into a merger agreement. Under the terms of the merger agreement, Auris Surgical Robotics will offer Hansen Medical shareholders $4.00 per share in cash for all outstanding shares.    

Based in Mountain View, CA, and founded in 2002 Hansen Medical Inc develops, manufactures, and sells medical robotics designed for the positioning, manipulation, and control of catheters and catheter-based technologies.

The investigation focuses on whether NASDAQ: HNSN investors received the highest price and whether the directors of Hansen Medical Inc acted in the best interest of Hansen Medical Inc company and its shareholders.   

If you purchased Hansen Medical Inc (NASDAQ: HNSN) prior to April 20, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185